Tabimorelin

193079-69-5

CAS-Nr.: 193079-69-5

Englisch Name:: Tabimorelin

Synonyma:: NNC260703;NNC-260703;NNC26-0703;NNC-26-0703;Tabimorelin;Unii-L51cbe03kf;Tabimorelin [inn];N-[5-Amino-5-Methyl-2(E)-Hexenoyl]-N-Methyl-3-(2- Naphthyl)-D-Alanyl-N-Methyl-D-Phenylalanine Methylamide;D-Phenylalaninamide, N-[(2E)-5-amino-5-methyl-1-oxo-2-hexen-1-yl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-;N-[(2E)-5-Amino-5-methyl-1-oxo-2-hexenyl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamidehemifumarate

CBNumber:: CB31074328

Summenformel:: C32H40N4O3

Molgewicht:: 528.68

MOL-Datei:: 193079-69-5.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 22

Tabimorelin Eigenschaften

Schmelzpunkt:: >70°C(dec.)

Siedepunkt:: 794.4±60.0 °C(Predicted)

Dichte: 1.146±0.06 g/cm3(Predicted)

storage temp.: Desiccate at RT

Löslichkeit: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)

pka: 15.14±0.46(Predicted)

Aggregatzustand: Solid

Farbe: White to Off-White

Stabilität:: Light Sensitive

Sicherheit

Tabimorelin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.

Biologische Aktivität

Potent, orally active ghrelin receptor (GHS-R1a) agonist (K i = 50 nM at human recombinant GHS-R1a). Stimulates GH release from rat pituitary cells with an EC 50 value of 2.7 nM. Induces hyperphagia and adiposity in lean rats, but not in leptin signaling-deficient ZDF rats.

Tabimorelin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Tabimorelin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 22)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15848	69
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15421	60
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12338	58
EMMX Biotechnology LLC	888-539-0666	info@emmx.com	United States	8449	60
Hangzhou Peptidego Biotech Co.,Ltd.	0571-87213919	eric@peptidego.com	China	6347	58
Jiangsu Hongmin Pharmaceutical Co., Ltd.	18221292452	fannieliu@glschina.com	China	6799	58
Shanghai Ruipu Medical Technology Co., Ltd	15895968936	1018762393@qq.com	China	9862	58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD	17306812703	3007955328@qq.com	China	5949	58
LGC Science (Shanghai) Ltd.	17717235263	cindy.yang@lgcgroup.com	China	11437	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016	3287908757@qq.com	China	9887	58

Tabimorelin
Tabimorelin [inn]
Unii-L51cbe03kf
N-[(2E)-5-Amino-5-methyl-1-oxo-2-hexenyl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-D-phenylalaninamidehemifumarate
N-[5-Amino-5-Methyl-2(E)-Hexenoyl]-N-Methyl-3-(2- Naphthyl)-D-Alanyl-N-Methyl-D-Phenylalanine Methylamide
NNC260703
NNC-260703
NNC-26-0703
NNC26-0703
D-Phenylalaninamide, N-[(2E)-5-amino-5-methyl-1-oxo-2-hexen-1-yl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-
193079-69-5
C32H40N4O3189C4H4O4
C32H40N4O3
Amines
Chiral Reagents
Inhibitors
Intermediates & Fine Chemicals
Pharmaceuticals